ERBB2 overexpression in breast carcinomas - no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

Author： Vincent-Salomon A.   Carton M.   Freneaux P.   Palangie T.   Beuzeboc P.   Mouret E.   de Cremoux P.   Coue O.   Zafrani B.   Nicolas A.   Clough K.   Fourquet A.   Pouillart P.   Sastre-Garau X.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.5, 2000-03, pp. : 586-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Response to Preoperative Anthracycline-Based Chemotherapy in Locally Advanced Breast Cancer: The Relevance of Proliferation and Apoptosis Rates

By Kanjer Ksenija  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 577-588

Springer Publishing Company

Access to resources Recommend Favorite

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

By Petit Thierry  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 387-391

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican Population of locally advanced breast cancer patients

By Muñoz-Gonzalez David   Zeichner-Gancz Isabel   Candelaria Myrna   Ramirez-Ugalde Maria   Perez-Sanchez Manuel   Cervantes-Vazquez Guadalupe   Cantu-de Leon David   Mora-Tizcareño Arcelia   Leonor-Ortíz Julio  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 23-28

Humana Press, Inc

Access to resources Recommend Favorite

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

By Wang Jiayu  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 531-537

Springer Publishing Company

Access to resources Recommend Favorite

Economic Analyses of Toxicity Secondary to Anthracycline-based Breast Cancer Chemotherapy

By Dranitsaris G.   Tran T.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2174-2180

Elsevier

Access to resources Recommend Favorite